{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:27:00Z","timestamp":1777994820636,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["102844"],"award-info":[{"award-number":["102844"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4737-3","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T06:42:53Z","timestamp":1536734573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Study protocol: HepaT1ca \u2013 an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-7302","authenticated-orcid":false,"given":"Damian J.","family":"Mole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenella","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott I.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Velicia","family":"Bachtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Wigmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"James Garden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry R.","family":"Wilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajarshi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrddin","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"issue":"6","key":"4737_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1478-3231.2008.01777.x","volume":"28","author":"MA van den Broek","year":"2008","unstructured":"van den Broek MA, Olde Damink SW, Dejong CH, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28(6):767\u201380. \n                    https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01777.x\n                    \n                  .","journal-title":"Liver Int"},{"issue":"4","key":"4737_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S2468-1253(16)30205-9","volume":"2","author":"R Harris","year":"2017","unstructured":"Harris R, Harman DJ, Card TR, et al. Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. Lancet Gastroenterol Hepatol. 2017;2(4):288\u201397. \n                    https:\/\/doi.org\/10.1016\/S2468-1253(16)30205-9\n                    \n                  . [published Online First: 2017\/02\/01]","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"4737_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384. \n                    https:\/\/doi.org\/10.1002\/hep.28431\n                    \n                  . [published Online First: 2016\/02\/22]","journal-title":"Hepatology"},{"issue":"1","key":"4737_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.sla.0000225113.88433.cf","volume":"245","author":"R Vetel\u00e4inen","year":"2007","unstructured":"Vetel\u00e4inen R, van Vliet A, Gouma DJ, et al. Steatosis as a risk factor in liver surgery. Ann Surg. 2007;245(1):20\u201330. \n                    https:\/\/doi.org\/10.1097\/01.sla.0000225113.88433.cf\n                    \n                  .","journal-title":"Ann Surg"},{"issue":"8","key":"4737_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/bjs.5672","volume":"94","author":"R Vetel\u00e4inen","year":"2007","unstructured":"Vetel\u00e4inen R, Bennink RJ, van Vliet AK, et al. Mild steatosis impairs functional recovery after liver resection in an experimental model. Br J Surg. 2007;94(8):1002\u20138. \n                    https:\/\/doi.org\/10.1002\/bjs.5672\n                    \n                  .","journal-title":"Br J Surg"},{"issue":"1","key":"4737_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","volume":"60","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60(1):69\u201377. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2013.09.002\n                    \n                  .","journal-title":"J Hepatol"},{"issue":"2","key":"4737_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jhep.2015.10.009","volume":"64","author":"M Pavlides","year":"2016","unstructured":"Pavlides M, Banerjee R, Sellwood J, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 2016;64(2):308\u201315. \n                    https:\/\/doi.org\/10.1016\/j.jhep.2015.10.009\n                    \n                  . [published Online First: 2015\/11\/10]","journal-title":"J Hepatol"},{"issue":"2","key":"4737_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1365-2168.2001.01658.x","volume":"88","author":"EK Abdalla","year":"2001","unstructured":"Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88(2):165\u201375. \n                    https:\/\/doi.org\/10.1046\/j.1365-2168.2001.01658.x\n                    \n                  .","journal-title":"Br J Surg"},{"issue":"1","key":"4737_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","volume":"247","author":"A Abulkhir","year":"2008","unstructured":"Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49\u201357. \n                    https:\/\/doi.org\/10.1097\/SLA.0b013e31815f6e5b\n                    \n                  .","journal-title":"Ann Surg"},{"issue":"2","key":"4737_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/lt.23552","volume":"19","author":"ER Garwood","year":"2013","unstructured":"Garwood ER, Fidelman N, Hoch SE, et al. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction. Liver Transpl. 2013;19(2):164\u201373. \n                    https:\/\/doi.org\/10.1002\/lt.23552\n                    \n                  . [published Online First: 2012\/12\/12]","journal-title":"Liver Transpl"},{"key":"4737_CR11","unstructured":"Horizon2020. HORIZON 2020 \u2013 WORK PROGRAMME 2014-2015. General Annexes. G. Technology readiness levels (TRL). 2015. Available from: \n                    http:\/\/ec.europa.eu\/research\/participants\/data\/ref\/h2020\/wp\/2014_2015\/annexes\/h2020-wp1415-annex-g-trl_en.pdf\n                    \n                  . Accessed 30 July 2018."},{"issue":"6","key":"4737_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jamcollsurg.2013.01.004","volume":"216","author":"O Hyder","year":"2013","unstructured":"Hyder O, Pulitano C, Firoozmand A, et al. A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg. 2013;216(6):1049\u201356. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2013.01.004\n                    \n                  . [published Online First: 2013\/03\/09]","journal-title":"J Am Coll Surg"},{"issue":"5","key":"4737_CR13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/jhep.1997.v26.pm0009362359","volume":"26","author":"K Kubota","year":"1997","unstructured":"Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26(5):1176\u201381. \n                    https:\/\/doi.org\/10.1053\/jhep.1997.v26.pm0009362359\n                    \n                  .","journal-title":"Hepatology"},{"issue":"10","key":"4737_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1245\/s10434-006-9045-5","volume":"13","author":"EK Abdalla","year":"2006","unstructured":"Abdalla EK, Adam R, Bilchik AJ, et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13(10):1271\u201380. \n                    https:\/\/doi.org\/10.1245\/s10434-006-9045-5\n                    \n                  . [published Online First: 2006\/09\/06]","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4737_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000335713","volume":"29","author":"A Guglielmi","year":"2012","unstructured":"Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection? Dig Surg. 2012;29(1):6\u201317. \n                    https:\/\/doi.org\/10.1159\/000335713\n                    \n                  . [published Online First: 2012\/03\/15]","journal-title":"Dig Surg"},{"issue":"1","key":"4737_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1148\/radiol.10091790","volume":"256","author":"JR van Werven","year":"2010","unstructured":"van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256(1):159\u201368. \n                    https:\/\/doi.org\/10.1148\/radiol.10091790\n                    \n                  .","journal-title":"Radiology"},{"issue":"6","key":"4737_CR17","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/hep.25935","volume":"56","author":"SK Reddy","year":"2012","unstructured":"Reddy SK, Marsh JW, Varley PR, et al. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology. 2012;56(6):2221\u201330. \n                    https:\/\/doi.org\/10.1002\/hep.25935\n                    \n                  . [published Online First: 2012\/10\/14]","journal-title":"Hepatology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4737-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T04:17:12Z","timestamp":1569385032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4737-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4737"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4737-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"27 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been reviewed as IRAS 223180 by the South East Scotland Research Ethics Committee 02, 17\/SS\/0049 who gave a favourable opinion. NHS Scotland R&D approval and NHS England HRA approval have been granted. The study sponsor is University of Edinburgh\/NHS Lothian ACCORD. This study is registered on ClinicalTrials.gov Identifier: NCT03213314.All individuals recruited to the study participated freely and after fully-informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the submission of this manuscript for publication. No restriction of future publication of data is made by any of the study partners.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The University of Edinburgh members declare no conflict of interest with this study. Similarly, employees of Basingstoke and North Hampshire Hospital declare no conflict of interest. Perspectum Diagnostics Ltd. is a privately-funded small commercial enterprise that develops MRI-based medical devices to address unmet clinical needs, including Liver<i>MultiScan\u2122<\/i>. As the industrial partner in this study, it has a commercial interest in the outcome.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"890"}}